Patient Pathfinder: Clinical Trials
Clinical Trials for Non Hodgkin Lymphoma
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 529 active Non Hodgkin Lymphoma trials
A Study to Assess Safety and Efficacy of CHO-H01 in Subjects With Refractory or Relapsed Non-Hodgkin’s Lymphoma
Study Type: Interventional Phase 1
A Study of CLN-978 in Patients With Relapsed or Refractory (R/R) B Cell Non-Hodgkin Lymphoma (B-NHL)
Study Type: Interventional Phase 1
Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)
Study Type: Interventional Phase 1
Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies
Study Type: Interventional Phase 1
Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter’s Syndrome
Study Type: Interventional Phase 2
Effects of Maplirpacept (PF-07901801),Tafasitamab, and Lenalidomide in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Study Type: Interventional Phase 2
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Study Type: Interventional Phase 1
Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma
Study Type: Interventional Phase 1
There are 529 active Non Hodgkin Lymphoma trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now